Consumer Health Healthcare
The CE-IVD marked QIAstat-Dx Respiratory SARS-CoV-2 Panel is available in Malaysia expanded to 23 pathogens, now includes Chlamydophila pneumoniae&nb...
June 04, 2024 | News
OBiO Technology, a world leading contract development and manufacturing organization for cell and gene therapy, officially launched the "Center f...
May 31, 2024 | News
Hitachi High-Tech Corporation ("Hitachi High-Tech") announced that Roche and Hitachi High-Tech have extended their partnership, committing to at least 10...
May 28, 2024 | News
Innovent Biologics, a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of canc...
May 28, 2024 | News
Vatech, a global leader in the dental imaging market, is launching a project to improve dental healthcare in South Africa. Vatech announced that it ha...
May 24, 2024 | News
Millions of women around the world continue to suffer unnecessarily from the physical and psychological effects of the menopause because of "mistaken fears...
May 24, 2024 | News
Eisai Co., Ltd. and nippon medac Co., Ltd., a subsidiary of the medac group, announced the launch of the anti-rheumatic agent "Metoject® Subcut...
May 23, 2024 | News
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, proudly announces the successful completion of i...
May 23, 2024 | News
Agreement for up to £465,000 signed for Optimer development Optimer binders will be developed for use in a cervical cance...
May 22, 2024 | News
Smart waste management in hospitals has been increasingly important for achieving the higher standards of safety and environmental expectation required by ...
May 22, 2024 | News
Dignitana has signed a new multi-year Distribution Agreement for technology market leader Konica Minolta to be the exclusive provider of The...
May 22, 2024 | News
Amplexd Therapeutics, Inc. (“Amplexd” or the “Company”), a clinical stage patient-scientist-led biotech company specializing in acc...
May 20, 2024 | News
Bayer will present detailed results from the pivotal Phase III studies OASIS 1 and 2, showing that the investigational compound elinzanetant significantly ...
May 17, 2024 | News
The Global Health Innovative Technology (GHIT) Fund announced a substantial investment of approximately JPY 1.64 billion (USD 10.8 million) dedicated...
May 09, 2024 | News
Most Read
Bio Jobs
News
Editor Picks